EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma

Xiaoyan Qu, Luyao Guo, Mo Zhang, Zongguan Huang, Lanlan Cui, Yiming Hu, Xiaofei Zhao, Changwei Hu, Guanfei Zhang, Ying Li, Yongping Shao, Jiangang Long und 1 weitere

Antioxidants · 19.11.2026 · 15 (11) · 1505

DOI: 10.3390/antiox15111505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 19.11.2026. Verfasst von Xiaoyan Qu und 12 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation of Shaanxi Province Natural Science Basic Research Program, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired resistance to BRAF inhibitors such as vemurafenib remains a major challenge in the treatment of BRAF-mutant melanoma. Although mitochondrial dysfunction-mediated pyroptosis has emerged as a potential strategy for overcoming drug resistance, whether MoSe2 possesses intrinsic antitumor activity in the absence of external stimulation remains largely unexplored. Here, we demonstrate that MoSe2 reduces viability and induces lytic cell death to a greater extent in vemurafenib-resistant melanoma cells than in parental cells under the treatment conditions tested. Mechanistically, molecular dynamics simulations and experimental analyses reveal that MoSe2 colocalizes with mitochondria and induces mitochondrial stress, which is associated with mitochondrial dysfunction and activation of the caspase-3/GSDME-associated pyroptotic pathway in vitro. In vivo, adding MoSe2 to vemurafenib is associated with increased intratumoral dendritic cell and Tcell infiltration and with enhanced antitumor efficacy, prolonging survival in both subcutaneous and genetically engineered spontaneous melanoma models, with overall tolerability at the tested dose, although urea and hematological changes were observed. Collectively, this work identifies a previously underappreciated light-independent therapeutic activity of MoSe2 and shows that MoSe2-induced mitochondrial dysfunction is accompanied by caspase-3/GSDME-dependent lytic cell death, while adding MoSe2 to vemurafenib is associated with increased intratumoral immune infiltration and enhanced antitumor efficacy in the models tested.

Förderung

  • National Natural Science Foundation of China
  • Foundation of Shaanxi Province Natural Science Basic Research Program
  • Fundamental Research Funds for the Central Universities
  • Key Research and Development Program of Shaanxi Province of China
  • Key Research and Development Program of Shaanxi
  • National foreign experts project

Zitieren

APA

Qu, X., Guo, L., Zhang, M., Huang, Z., Cui, L., Hu, Y., Zhao, X., Hu, C., Zhang, G., Li, Y., Shao, Y., Long, J., & Han, S. (2026). MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma. Antioxidants, 15(11), 1505. https://doi.org/10.3390/antiox15111505

Vancouver

Qu X, Guo L, Zhang M, Huang Z, Cui L, Hu Y, et al. MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma. Antioxidants. 2026;15(11):1505. doi:10.3390/antiox15111505

BibTeX
@article{Qu2026,
  author = {Qu, Xiaoyan and Guo, Luyao and Zhang, Mo and Huang, Zongguan and Cui, Lanlan and Hu, Yiming and Zhao, Xiaofei and Hu, Changwei and Zhang, Guanfei and Li, Ying and Shao, Yongping and Long, Jiangang and Han, Shujun},
  title = {MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1505},
  doi = {10.3390/antiox15111505}
}
Kostenlos starten →